4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-20-009170
EVP/Chief Scientific Officer sold 10,000 shares at $35.29 ($352,900)
- EVP/Chief Scientific Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Albright Charles EVP/Chief Scientific Officer | 2020-08-17 | Option exercise | +10,000 | $16.51 | $165,100 | 38,135 | D: show line 1 in the form |
| Albright Charles EVP/Chief Scientific Officer | 2020-08-17 | Sale | −10,000 | $35.29 | $352,900 | 28,135 | D: show line 2 in the form |
| Open-market sales · 10,000 sh · avg $35.29 · $352,900 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Albright Charles EVP/Chief Scientific Officer | 2020-08-17 | Option exercise · Stock Option (right to buy) | −10,000 | 185,000 | D: show line 3 in the form |
Loading xslF345X03/edgar.xml…